Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Summit Therapeutics Inc (NASDAQ: SMMT) closed at $7.54 down -7.37% from its previous closing price of $8.14. In other words, the price has decreased by -$7.37 from its previous closing price. On the day, 2.67 million shares were traded. SMMT stock price reached its highest trading level at $8.19 during the session, while it also had its lowest trading level at $7.53.
Ratios:
For a deeper understanding of Summit Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.97 and its Current Ratio is at 6.97. In the meantime, Its Debt-to-Equity ratio is 2.48 whereas as Long-Term Debt/Eq ratio is at 2.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on May 07, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On March 26, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.
Zanganeh Mahkam bought 26,000 shares of SMMT for $96,720 on Mar 27 ’24. The Chief Executive Officer now owns 520,814 shares after completing the transaction at $3.72 per share. On Mar 26 ’24, another insider, Dhingra Ankur, who serves as the Chief Financial Officer of the company, bought 100,000 shares for $3.75 each. As a result, the insider paid 375,000 and bolstered with 354,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 5714113536 and an Enterprise Value of 5245768192.
Stock Price History:
The Beta on a monthly basis for SMMT is -0.97, which has changed by 2.2222223 over the last 52 weeks, in comparison to a change of 0.23886502 over the same period for the S&P500. Over the past 52 weeks, SMMT has reached a high of $11.25, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is 27.72%, while the 200-Day Moving Average is calculated to be 103.00%.
Shares Statistics:
For the past three months, SMMT has traded an average of 4.07M shares per day and 3146150 over the past ten days. A total of 701.66M shares are outstanding, with a floating share count of 83.22M. Insiders hold about 88.14% of the company’s shares, while institutions hold 7.11% stake in the company. Shares short for SMMT as of 1718323200 were 23431956 with a Short Ratio of 5.75, compared to 1715731200 on 22565474. Therefore, it implies a Short% of Shares Outstanding of 23431956 and a Short% of Float of 28.120002.
